Open access · CC-BY
via OpenAlex
Unraveling the meta-hallmarks between senescent and tumor cells: A new perspective for senolytic drug discovery
Wei Liu, Bo Fan, Te Fang, Hongyao Li, Jin Zhang, Bo Liu, Zhiyu Liu
Acta Pharmaceutica Sinica B · 2025 · ▲ 10 citations
Abstract
Aging and cancer share overlapping characteristics, referred to as meta-hallmarks, which elucidate the convergent, antagonistic, or contradictory relationships between aging and cancer. Likewise, as a key characteristic of aging, senescent cells share some meta-hallmarks with tumor cells. These hallmarks include apoptosis resistance, metabolic alterations, secretory phenotypes, epigenetic reprogramming, and immune surveillance, all of which play pivotal roles in both tumorigenesis and senescence(definition). Moreover, senolytic drugs, which are a class of agents selectively designed to eliminate senescent cells, have emerged as promising therapeutic agents in oncology and aging-related diseases. Since the discovery of the first senolytic drug in 2015, a diverse array of such agents has been developed. Notably, most senolytic drugs are repurposed from existing anti-tumor therapies, leveraging their shared mechanisms with senescent cells and tumor cells. Thus, this review examines the similarities between senescent cells and tumor cells, providing a better understanding of the meta-hallmarks. Besides, we categorize existing senolytic drugs based upon meta-hallmarks and elucidate the potential molecular mechanisms underlying their effects. By integrating insights from cancer and senescence research, this work aims to inspire innovative strategies for senolytic drug discovery.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1016/j.apsb.2025.08.010
- Canonical
- link ↗
- Fetched
- 2026-11-12 MST
Cite this
APA
Liu, W., Fan, B., Fang, T., Li, H., Zhang, J., Liu, B., & Liu, Z. (2025). Unraveling the meta-hallmarks between senescent and tumor cells: A new perspective for senolytic drug discovery. <em>Acta Pharmaceutica Sinica B</em>. https://doi.org/10.1016/j.apsb.2025.08.010
Vancouver
Liu W, Fan B, Fang T, Li H, Zhang J, Liu B, et al. Unraveling the meta-hallmarks between senescent and tumor cells: A new perspective for senolytic drug discovery. Acta Pharmaceutica Sinica B. 2025. doi:10.1016/j.apsb.2025.08.010.
BibTeX
@article{wei2025Unrave,
title = {Unraveling the meta-hallmarks between senescent and tumor cells: A new perspective for senolytic drug discovery},
author = {Wei Liu and Bo Fan and Te Fang and Hongyao Li and Jin Zhang and Bo Liu and Zhiyu Liu},
journal = {Acta Pharmaceutica Sinica B},
year = {2025},
doi = {10.1016/j.apsb.2025.08.010},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Cell Metabolism 2023
Open access · OA
Meta-hallmarks of aging and cancer
Biomedicines 2026
Open access · OA
The Bidirectional Role of Cellular Senescence in the Treatment of Ovarian Cancer.
MedComm 2024
Open access · CC-BY
Cellular senescence in cancer: molecular mechanisms and therapeutic targets
Molecular Metabolism 2022
Open access · CC-BY
Targeting cellular senescence in metabolic disease
eLife 2020
Open access · CC-BY
Senotherapeutic drugs for human intervertebral disc degeneration and low back pain
Journal of Cell Communication and Signaling 2017
Open access · CC-BY